Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Remuzzi

Showing results (61-70 of 894) with videos related to

Pageof 90
Sort By:
The Lancet. Diabetes & Endocrinology|May 6, 2014
Dreaming of normoglycaemia with fewer diet restrictionsPiero Ruggenenti, Giuseppe Remuzzi
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 3, 2015
Glomerular Diseases Dependent on Complement Activation, Including Atypical Hemolytic Uremic Syndrome, Membranoproliferative Glomerulonephritis, and C3 Glomerulopathy: Core Curriculum 2015Marina Noris, Giuseppe Remuzzi
Nature Reviews. Nephrology|June 11, 2014
Clinical trials: ISN-ACCTS: global initiatives to improve clinical researchAdeera Levin, Giuseppe Remuzzi
Kidney International|April 20, 2025
Kidney organoids: a 3-dimensional tool to unmask permeability factors in primary and recurrent FSGSFederica Casiraghi, Giuseppe Remuzzi
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|August 20, 2002
The renin-angiotensin system in progression, remission and regression of chronic nephropathiesClaudio Aros, Giuseppe Remuzzi
Journal of the American Society of Nephrology : JASN|April 23, 2003
Can we really lessen kidney damage to the point that the loss of renal function of progressive nephropathy may revert?Mauro Abbate, Giuseppe Remuzzi
Kidney International|June 24, 2019
Terminal complement effectors in atypical hemolytic uremic syndrome: C5a, C5b-9, or a bit of both?Marina Noris, Giuseppe Remuzzi
The New England Journal of Medicine|July 4, 2019
A First Step toward a New Approach to Treating Membranous NephropathyPiero Ruggenenti, Giuseppe Remuzzi
Seminars in Nephrology|September 3, 2010
Genetics and genetic testing in hemolytic uremic syndrome/thrombotic thrombocytopenic purpuraMarina Noris, Giuseppe Remuzzi
Nature Reviews. Nephrology|November 27, 2010
Do mTOR inhibitors still have a future in ADPKD?Norberto Perico, Giuseppe Remuzzi
Pageof 90

Showing results (61-70 of 894) with videos related to

Sort By:
Pageof 90
The Lancet. Diabetes & Endocrinology|May 6, 2014
Dreaming of normoglycaemia with fewer diet restrictionsPiero Ruggenenti, Giuseppe Remuzzi
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 3, 2015
Glomerular Diseases Dependent on Complement Activation, Including Atypical Hemolytic Uremic Syndrome, Membranoproliferative Glomerulonephritis, and C3 Glomerulopathy: Core Curriculum 2015Marina Noris, Giuseppe Remuzzi
Nature Reviews. Nephrology|June 11, 2014
Clinical trials: ISN-ACCTS: global initiatives to improve clinical researchAdeera Levin, Giuseppe Remuzzi
Kidney International|April 20, 2025
Kidney organoids: a 3-dimensional tool to unmask permeability factors in primary and recurrent FSGSFederica Casiraghi, Giuseppe Remuzzi
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|August 20, 2002
The renin-angiotensin system in progression, remission and regression of chronic nephropathiesClaudio Aros, Giuseppe Remuzzi
Journal of the American Society of Nephrology : JASN|April 23, 2003
Can we really lessen kidney damage to the point that the loss of renal function of progressive nephropathy may revert?Mauro Abbate, Giuseppe Remuzzi
Kidney International|June 24, 2019
Terminal complement effectors in atypical hemolytic uremic syndrome: C5a, C5b-9, or a bit of both?Marina Noris, Giuseppe Remuzzi
The New England Journal of Medicine|July 4, 2019
A First Step toward a New Approach to Treating Membranous NephropathyPiero Ruggenenti, Giuseppe Remuzzi
Seminars in Nephrology|September 3, 2010
Genetics and genetic testing in hemolytic uremic syndrome/thrombotic thrombocytopenic purpuraMarina Noris, Giuseppe Remuzzi
Nature Reviews. Nephrology|November 27, 2010
Do mTOR inhibitors still have a future in ADPKD?Norberto Perico, Giuseppe Remuzzi
Pageof 90